Comparative Analysis of Long COVID and Post-Vaccination Syndrome: A Cross-Sectional Study of Clinical Symptoms and Machine Learning-Based Differentiation

Long COVID is a well-documented post-viral syndrome, while post-vaccination syndrome (PVS) remains poorly characterized. Understanding their similarities and differences is essential for refining diagnostic criteria and developing targeted interventions. This study systematically compares the symptomatology of long COVID and PVS following COVID-19 vaccination, highlighting key distinctions that could inform clinical practice and research. To assess the clinical characteristics of long COVID and PVS and identify key distinguishing features between the conditions. This cross-sectional analysis used questionnaire data from the decentralized Yale Listen to Immune, Symptom and Treatment Experiences Now (LISTEN) Study, collected from May 2022 to July 2023. Data analysis occurred between July 2023 and May 2024. A convenience sample of adults (age ≥18 years) with either long COVID or PVS was included. Symptom data were analyzed using clustering techniques to identify groups with shared symptom patterns. A gradient-boosted machine learning model was used to determine the most distinguishing symptoms between long COVID and PVS. The long COVID group (n = 441) and PVS group (n = 241) had similar demographic profiles (median age 46 years; 74% vs 80% female, respectively). Participants with long COVID most commonly reported brain fog, altered sense of smell and taste, shortness of breath, fatigue, memory problems, and difficulty speaking. Participants with PVS more frequently reported burning sensations, neuropathy, and numbness. Clustering analysis identified three symptom-based subgroups: one enriched for neurological symptoms and PVS; one characterized by multi-system symptoms and predominantly long COVID; and one dominated by psychiatric and sleep symptoms, also primarily long COVID. The machine learning model achieved an AUC of 0.79 (95% CI, 0.75–0.82) and highlighted altered sense of smell, cough, burning sensations, and brain fog as key differentiators. Although long COVID and PVS share overlapping symptoms, they have distinct clinical profiles, suggesting the possibility of different underlying biological mechanisms. These distinctions may help refine diagnostic criteria, guide personalized treatment strategies, and inform further research into their respective pathophysiology. What are the similarities and differences between long COVID and post-vaccination syndrome (PVS)? In this cross-sectional study of 682 individuals, machine learning models identified distinct symptoms between long COVID and PVS. Long COVID was characterized by brain fog, altered sense of smell, and shortness of breath, while PVS was associated with burning sensations, neuropathy, and numbness. Although long COVID and PVS share overlapping symptoms, they have distinctive symptom profiles, suggesting potentially different underlying biological mechanisms. Understanding these differences can guide clinical diagnosis and targeted management, and inform further research into their distinct immune and biological pathways.